A detailed history of Creative Planning transactions in Astrazeneca PLC stock. As of the latest transaction made, Creative Planning holds 224,751 shares of AZN stock, worth $14.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
224,751
Previous 208,059 8.02%
Holding current value
$14.9 Million
Previous $16.2 Million 7.93%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$76.67 - $87.62 $1.28 Million - $1.46 Million
16,692 Added 8.02%
224,751 $17.5 Million
Q2 2024

Aug 15, 2024

BUY
$66.81 - $80.83 $2.15 Million - $2.6 Million
32,132 Added 18.26%
208,059 $16.2 Million
Q1 2024

May 10, 2024

BUY
$61.03 - $69.57 $1.77 Million - $2.02 Million
29,057 Added 19.78%
175,927 $11.9 Million
Q4 2023

Feb 14, 2024

SELL
$61.89 - $69.28 $1.35 Million - $1.51 Million
-21,795 Reduced 12.92%
146,870 $9.89 Million
Q3 2023

Nov 16, 2023

BUY
$64.85 - $71.7 $855,306 - $945,651
13,189 Added 8.48%
168,665 $11.4 Million
Q2 2023

Jul 21, 2023

BUY
$69.91 - $75.81 $1.41 Million - $1.53 Million
20,172 Added 14.91%
155,476 $11.1 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $272,871 - $309,383
4,321 Added 3.3%
135,304 $9.39 Million
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $953,770 - $1.24 Million
17,594 Added 15.52%
130,983 $8.88 Million
Q3 2022

Nov 03, 2022

BUY
$53.02 - $135.75 $651,668 - $1.67 Million
12,291 Added 12.16%
113,389 $6.22 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $26,726 - $32,084
451 Added 0.45%
101,098 $6.68 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $1.88 Million - $2.27 Million
33,809 Added 50.58%
100,647 $6.68 Million
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $80,489 - $95,106
-1,490 Reduced 2.18%
66,838 $3.89 Million
Q3 2021

Nov 10, 2021

BUY
$55.56 - $60.79 $643,829 - $704,434
11,588 Added 20.42%
68,328 $4.1 Million
Q2 2021

Aug 04, 2021

SELL
$48.42 - $60.18 $452,339 - $562,201
-9,342 Reduced 14.14%
56,740 $3.4 Million
Q1 2021

Apr 30, 2021

SELL
$47.16 - $54.44 $83,991 - $96,957
-1,781 Reduced 2.62%
66,082 $3.29 Million
Q4 2020

Jan 29, 2021

BUY
$48.52 - $58.02 $144,686 - $173,015
2,982 Added 4.6%
67,863 $3.39 Million
Q3 2020

Nov 05, 2020

BUY
$53.07 - $61.1 $259,087 - $298,290
4,882 Added 8.14%
64,881 $3.56 Million
Q2 2020

Jul 23, 2020

BUY
$43.1 - $55.31 $461,644 - $592,425
10,711 Added 21.73%
59,999 $3.17 Million
Q1 2020

May 05, 2020

BUY
$37.79 - $51.33 $160,607 - $218,152
4,250 Added 9.44%
49,288 $2.2 Million
Q4 2019

Jan 30, 2020

BUY
$42.46 - $50.46 $156,677 - $186,197
3,690 Added 8.92%
45,038 $2.25 Million
Q3 2019

Nov 01, 2019

SELL
$40.12 - $45.47 $56,448 - $63,976
-1,407 Reduced 3.29%
41,348 $1.84 Million
Q2 2019

Jul 26, 2019

BUY
$37.28 - $41.68 $2,945 - $3,292
79 Added 0.19%
42,755 $1.77 Million
Q1 2019

Apr 24, 2019

SELL
$35.49 - $43.02 $105,156 - $127,468
-2,963 Reduced 6.49%
42,676 $1.73 Million
Q4 2018

Feb 01, 2019

BUY
$36.86 - $41.49 $160,599 - $180,771
4,357 Added 10.55%
45,639 $1.73 Million
Q3 2018

Oct 25, 2018

BUY
$34.76 - $39.72 $179,292 - $204,875
5,158 Added 14.28%
41,282 $1.63 Million
Q2 2018

Jul 20, 2018

SELL
$34.55 - $37.05 $16,100 - $17,265
-466 Reduced 1.27%
36,124 $1.27 Million
Q1 2018

Apr 18, 2018

BUY
$32.97 - $36.63 $5,802 - $6,446
176 Added 0.48%
36,590 $1.28 Million
Q4 2017

Jan 17, 2018

SELL
$32.09 - $34.78 $4,749 - $5,147
-148 Reduced 0.4%
36,414 $1.26 Million
Q3 2017

Oct 17, 2017

BUY
$28.96 - $34.0 $1.06 Million - $1.24 Million
36,562
36,562 $1.24 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.